BioCatalystWatch
OVIDWorkspace / OVID / OverviewCompany library
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc.

Ovid Therapeutics Inc. (OVID)

Website

Price
Market cap
Next catalystTSC initiation Q4 2026, pending necessary regulatory clearancesPediatric formulation of OV329 — open-label TSC study · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

OV329

GABA aminotransferase (GABA-AT)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

OV329

GABA aminotransferase (GABA-AT)

Upcoming / outlook

pediatric formulation of OV329Pediatric formulation of OV329 — open-label TSC study

GABA-AT

Upcoming / outlook

pediatric formulation of OV329

GABA-AT

Upcoming / outlook

OV4071

KCC2

PreINDP1P3FilingApproved
Upcoming / outlook

OV4071

KCC2

OV4071

KCC2

PreINDP1P2P3FilingApproved
Upcoming / outlook

OV4071

KCC2

Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

OV4071

KCC2

Upcoming / outlook

  • Timing and evidence

pediatric formulation of OV329Pediatric formulation of OV329 — open-label TSC study

GABA-AT

Upcoming / outlook

OV329

GABA aminotransferase (GABA-AT)

Upcoming / outlook

OV4071

KCC2

PreINDP1P2P3FilingApproved
Upcoming / outlook

OV4071

KCC2

PreINDP1P3FilingApproved
Upcoming / outlook

pediatric formulation of OV329

GABA-AT

Upcoming / outlook

Other pipelines

OV888/GV101

ROCK2

PreINDP1P2P3FilingApproved
OV329

GABA aminotransferase (GABA-AT)

PreINDP1P2P3FilingApproved

History / paused

Extrasynaptic δ-containing GABAA receptor

PreINDP1P2P3FilingApproved

UBE3A antisense RNA

PreINDP1P2P3FilingApproved

Cholesterol 24-hydroxylase (CH24H/CYP46A1)

PreINDP1P2P3FilingApproved

Cholesterol 24-hydroxylase (CH24H/CYP46A1)

PreINDP1P2P3FilingApproved

Cholesterol 24-hydroxylase (CH24H/CYP46A1)

PreINDP1P2P3FilingApproved

Cholesterol 24-hydroxylase (CH24H/CYP46A1)

PreINDP1P2P3FilingApproved
OV329

GABA aminotransferase (GABA-AT)

IND

PreINDP1P2P3FilingApproved

KCC2

PreINDP1P2P3FilingApproved

KCC2

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

OVID PR & News

PR & News

OVID SEC archive